SCHEDULE 13GAccepted Aug 13, 6:00 PM ET
ArriVent BioPharma, Inc. SCHEDULE 13G
Accepted (ET)
6:00 PM
Aug 13, 2025
Filed
Aug 13, 2025
Documents
1
Size
9.9 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.